Neuroprotective role of VEGF induced in response to photodynamic therapy

Advances in Neuroimmune Biology

Volumn 4, Issue 3, 2013, Pages 161-165

  Ozawa, Yoko ^a   Suzuki, Misa ^a   Niikura, Serina ^a   Kamoshita, Mamoru ^a   Nagai, Norihiro ^a   Tsubota, Kazuo ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

AKT; neuron; retina; VEGF

Indexed keywords

HYPOXIA INDUCIBLE FACTOR; REACTIVE OXYGEN METABOLITE; VASCULOTROPIN; VASCULOTROPIN INHIBITOR; VASCULOTROPIN RECEPTOR; VERTEPORFIN;

APOPTOSIS; ARTICLE; CELL DEATH; CELL STRESS; CELL SURVIVAL; DISEASE ACTIVITY; EXUDATE; HUMAN; HYPOXIA; INFLAMMATION; INTRACELLULAR SIGNALING; LASER; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PHOTODYNAMIC THERAPY; PIGMENT EPITHELIUM; POLYPOIDAL CHOROIDAL VASCULOPATHY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETINA; RETINA MACULA AGE RELATED DEGENERATION; RETINA NEUROEPITHELIAL LAYER; SUBRETINAL NEOVASCULARIZATION; THERAPY EFFECT; TREATMENT OUTCOME;

EID: 84896763000     PISSN: 1878948X     EISSN: 18789498     Source Type: Journal    
DOI: 10.3233/NIB-130062     Document Type: Article

References (42)

1. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: One-year results of 2 randomized clinical trials-TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group. Archives of Ophthalmology. 1999; 117(10): 1329-1245
2. Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin. 1-year results of a randomized clinical trial-VIP report no. 1. Ophthalmology. 2001; 108(5): 841-852
3. Husain D, Kramer M, Kenny AG, Michaud N, Flotte TJ, Gragoudas ES, et al. Effects of photodynamic therapy using verteporfin on experimental choroidal neovascularization and normal retina and choroid up to 7 weeks after treatment. Investigative Ophthalmology&Visual Science. 1999; 40(10): 2322-2331
4. Marmur ES, Schmults CD, Goldberg DJ. A review of laser and photodynamic therapy for the treatment of nonmelanoma skin cancer. Dermatol Surg. 2004; 30(2 Pt 2): 264-271
5. Japanese age-related macular degeneration trial: 1-year results of photodynamic therapy with verteporfin in Japanese patients with subfoveal choroidal neovascularization secondary to age-related macular degeneration. American Journal of Ophthalmology. 2003; 136(6): 1049-1061
6. Photodynamic therapy with verteporfin in Japanese patients with subfoveal choroidal neovascularization secondary to age-related macular degeneration (AMD): Results of the Japanese AMD Trial (JAT) extension. Jpn J Ophthalmol. 2008; 52(2): 99-107
7. Brown DM, Michels M, Kaiser PK, Heier JS, Sy JP, Ianchulev T. Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: Two-year results of the ANCHOR study. Ophthalmology. 2009; 116(1): 57-65 e5
8. Rosenfeld PJ, Brown DM, Heier JS, Boyer DS, Kaiser PK, Chung CY, et al. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med. 2006; 355(14): 1419-1431
9. Gragoudas ES, Adamis AP, Cunningham ET Jr, Feinsod M, Guyer DR. Pegaptanib for neovascular age-related macular degeneration. N Engl J Med. 2004; 351(27): 2805-2816
10. Heier JS, Brown DM, Chong V, Korobelnik JF, Kaiser PK, Nguyen QD, et al. Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration. Ophthalmology. 2012; 119(12): 2537-2548
11. Ferrara N. Vascular endothelial growth factor as a target for anticancer therapy. Oncologist. 2004; 9(Suppl 1): 2-10
12. Shweiki D, Itin A, Soffer D, Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxiainitiated angiogenesis. Nature. 1992; 359(6398): 843-845
13. Aiello LP, Avery RL, Arrigg PG, Keyt BA, Jampel HD, Shah ST, et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med. 1994; 331(22): 1480-1487
14. Izumi-Nagai K, Nagai N, Ohgami K, Satofuka S, Ozawa Y, Tsubota K, et al. Macular pigment lutein is antiinflammatory in preventing choroidal neovascularization. Arteriosclerosis, Thrombosis, and Vascular Biology. 2007; 27(12): 2555-2562
15. Nagai N, Oike Y, Izumi-Nagai K, Urano T, Kubota Y, Noda K, et al. Angiotensin II type 1 receptor-mediated inflammation is required for choroidal neovascularization. Arteriosclerosis, Thrombosis, and Vascular Biology. 2006; 26(10): 2252-2259
16. Ishida S, Usui T, Yamashiro K, Kaji Y, Ahmed E, Carrasquillo KG, et al. VEGF164 is proinflammatory in the diabetic retina. Investigative Ophthalmology & Visual Science. 2003; 44(5): 2155-2162
17. Koh AH, Chen LJ, Chen SJ, Chen Y, Giridhar A, Iida T, et al. POLYPOIDAL CHOROIDAL VASCULOPATHY: Evidence-Based Guidelines for Clinical Diagnosis and Treatment. Retina. 2013; 33(4): 686-716
18. Schmidt-Erfurth U, Schlotzer-Schrehard U, Cursiefen C, Michels S, Beckendorf A, Naumann GO. Influence of photodynamic therapy on expression of vascular endothelial growth factor (VEGF), VEGF receptor 3, and pigment epithelium-derived factor. Investigative Ophthalmology & Visual Science. 2003; 44(10): 4473-4480
19. Kaiser PK, Boyer DS, Garcia R, Hao Y, Hughes MS, Jabbour NM, et al. Verteporfin photodynamic therapy combined with intravitreal bevacizumab for neovascular age-related macular degeneration. Ophthalmology. 2009; 116(4): 747-755, 55 e1
20. Maharaj AS, Walshe TE, Saint-Geniez M, Venkatesha S, Maldonado AE, Himes NC, et al. VEGF and TGF-beta are required for the maintenance of the choroid plexus and ependyma. The Journal of Experimental Medicine. 2008; 205(2): 491-501
21. Nishijima K, Ng YS, Zhong L, Bradley J, Schubert W, Jo N, et al. Vascular endothelial growth factor-A is a survival factor for retinal neurons and a critical neuroprotectant during the adaptive response to ischemic injury. The American journal of pathology. 2007; 171(1): 53-67
22. Suzuki M, Ozawa Y, Kubota S, Hirasawa M, Miyake S, Noda K, et al. Neuroprotective response after photodynamic therapy: Role of vascular endothelial growth factor. J Neuroinflammation. 2011; 8: 176
23. Kim IK, Husain D, Michaud N, Connolly E, Lane AM, Durrani K, et al. Effect of intravitreal injection of ranibizumab in combination with verteporfin PDT on normal primate retina and choroid. Investigative Ophthalmology & Visual Science. 2006; 47(1): 357-363
24. Pages G, Pouyssegur J. Transcriptional regulation of the Vascular Endothelial Growth Factor gene-A concert of activating factors. Cardiovasc Res. 2005; 65(3): 564-573
25. Schafer G, Cramer T, Suske G, Kemmner W, Wiedenmann B, Hocker M. Oxidative stress regulates vascular endothelial growth factor-A gene transcription through Sp1-And Sp3-dependent activation of two proximal GC-rich promoter elements. The Journal of Biological Chemistry. 2003; 278(10): 8190-8198
26. Kurihara T, Kubota Y, Ozawa Y, Takubo K, Noda K, Simon MC, et al. von Hippel-Lindau protein regulates transition from the fetal to the adult circulatory system in retina. Development. 2010; 137(9): 1563-1571
27. Levy NS, Chung S, Furneaux H, Levy AP. Hypoxic stabilization of vascular endothelial growth factor mRNA by the RNA-binding protein HuR. The Journal of Biological Chemistry. 1998; 273(11): 6417-6423
28. Niu G, Wright KL, Huang M, Song L, Haura E, Turkson J, et al. Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis. Oncogene. 2002; 21(13): 2000-2008
29. Heidary G, Vanderveen D, Smith LE. Retinopathy of prematurity: Current concepts in molecular pathogenesis. Semin Ophthalmol. 2009; 24(2): 77-81
30. Pierce EA, Avery RL, Foley ED, Aiello LP, Smith LE. Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization. Proceedings of the National Academy of Sciences of the United States of America. 1995; 92(3): 905-909
31. Satofuka S, Ichihara A, Nagai N, Noda K, Ozawa Y, Fukamizu A, et al. (Pro)renin receptor promotes choroidal neovascularization by activating its signal transduction and tissue renin-Angiotensin system. The American Journal of Pathology. 2008; 173(6): 1911-1918
32. Koto T, Nagai N, Mochimaru H, Kurihara T, Izumi-Nagai K, Satofuka S, et al. Eicosapentaenoic acid is anti-inflammatory in preventing choroidal neovascularization in mice. Investigative Ophthalmology & Visual Science. 2007; 48(9): 4328-4334
33. Wang J, Xu X, Elliott MH, Zhu M, Le YZ. Muller cell-derived VEGF is essential for diabetes-induced retinal inflammation and vascular leakage. Diabetes. 2010; 59(9): 2297-2305
34. Ishida S, Usui T, Yamashiro K, Kaji Y, Amano S, Ogura Y, et al. VEGF164-mediated inflammation is required for pathological, but not physiological, ischemia-induced retinal neovascularization. The Journal of Experimental Medicine. 2003; 198(3): 483-489
35. Saint-Geniez M, Maharaj AS, Walshe TE, Tucker BA, Sekiyama E, Kurihara T, et al. Endogenous VEGF is required for visual function: Evidence for a survival role on muller cells and photoreceptors. PloS one. 2008; 3(11): E3554
36. Ford KM, Saint-Geniez M, Walshe T, Zahr A, D'Amore PA. Expression and role of VEGF in the adult retinal pigment epithelium. Investigative Ophthalmology & Visual Science. 2011; 52(13): 9478-9487
37. Zhao S, Overbeek PA. Regulation of choroid development by the retinal pigment epithelium. Molecular Vision. 2001; 7: 277-282
38. Marneros AG, Fan J, Yokoyama Y, Gerber HP, Ferrara N, Crouch RK, et al. Vascular endothelial growth factor expression in the retinal pigment epithelium is essential for choriocapillaris development and visual function. The American Journal of Pathology. 2005; 167(5): 1451-1459
39. Carmeliet P, Ferreira V, Breier G, Pollefeyt S, Kieckens L, Gertsenstein M, et al. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature. 1996; 380(6573): 435-439
40. Ferrara N, Carver-Moore K, Chen H, Dowd M, Lu L, O'Shea KS, et al. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature. 1996; 380(6573): 439-442
41. Saint-Geniez M, Kurihara T, Sekiyama E, Maldonado AE, D'Amore PA. An essential role for RPE-derived soluble VEGFin the maintenance of the choriocapillaris. Proceedings of the National Academy of Sciences of the United States of America. 2009; 106(44): 18751-18756
42. Greenberg DA, Jin K. From angiogenesis to neuropathology. Nature. 2005; 438(7070): 954-959